21 Recruiting Trials

Clinical Trials
for Diabetes in Oregon

21 clinical trials for Diabetes are currently recruiting participants at study sites in Oregon. Study-related care is provided at no cost.

21
Recruiting trials
12
Study sites
3
Cities
11
Industry-sponsored
3
Phase 2
9
Phase 3

Diabetes clinical trials in Oregon: what to expect

Diabetes is one of the largest areas of clinical research, and the trials differ a great deal by type. Type 2 studies most often test new glucose-lowering or weight-reducing medicines, once-weekly insulins, and combinations with GLP-1 drugs, in people whose A1c is above goal on their current treatment. Type 1 studies test automated insulin delivery systems, immune therapies for people recently diagnosed or at high risk, and cell-based approaches. Others focus on the complications: kidney disease, eye disease, nerve pain and foot ulcers.

In Oregon, recruiting diabetes studies are concentrated in Portland, Eugene and Bend. 11 of the 21 are run by a drug or device company, which usually means a larger study with travel reimbursement; the rest are academic or hospital-led.

Who diabetes trials usually look for

Type 2 trials typically ask for a confirmed diagnosis, an A1c in a stated range (often between 7 and 10.5 percent) and a stable dose of your current medicines for at least a few months. Many exclude recent insulin use, a recent heart attack or stroke, or kidney function below a cut-off. Type 1 trials are often limited by time since diagnosis and by age, and some enroll children and teenagers with a parent's consent.

You do not need to know your A1c or kidney numbers to ask about a trial; the site measures them at screening.

What taking part involves

Screening includes blood work and a review of your history. Medicine trials usually last six months to three years with visits every one to three months, and many provide a glucose monitor and supplies for the duration. Some compare a new drug with a standard one rather than a placebo, so everyone receives active treatment; others include a placebo arm, and the consent form says which. Study drugs, devices, visits and labs are provided at no cost, and most trials pay for time and travel.

Questions worth asking the study team

Whether you would stay on your current medicines; whether there is a placebo group; how often visits are and whether any can be done remotely; and whether your own doctor will receive the results of study labs. If you have type 1 diabetes, ask whether the study uses your own pump or monitor.

Showing 20 of 21 recruiting Diabetes trials in Oregon

Glycemic Metrics and Patterns in People With and Without Prediabetes
N/A Bend, Oregon NCT06921902
This trial is looking for adults to help understand blood sugar patterns in people with and without prediabetes. Participants will use a continuous glucose monitor to track their blood sugar levels.
Recruiting
Inhaled Insulin vs Rapid-acting Injections for Post-meal Glucose Control in Women With Gestational Diabetes
PHASE2 Portland, Oregon +4 sites NCT06535789
This trial is looking for pregnant women aged 18-40 who have gestational diabetes. Participants will try two types of insulin to see which one works better for controlling blood sugar after meals.
Recruiting
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
PHASE2 Chandler, Arizona +4 sites NCT07296484
This trial is looking for adults who are at least 18 years old and have type 2 diabetes that isn’t well controlled. They should have been on stable diabetes medications for a while and show signs of high cortisol levels. However, it won't include anyone who just started having diabetes, has serious low blood sugar issues, or works night shifts regularly.
Recruiting
PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes
PHASE4 Huntsville, Alabama +4 sites NCT05390892
This trial is looking for people with type 2 diabetes and heart disease or at high risk for heart disease. Participants will take one of two medications and will be monitored for heart, kidney, and death-related events over time.
Recruiting
App-Based Certified Diabetes Education Therapy (AB-CDE)
NA Los Angeles, California +4 sites NCT07282639
This trial is looking for adults with type 1 diabetes who want to use a smartphone app to help manage their blood sugar levels. Participants will track their glucose data and receive personalized recommendations for insulin and carbs during exercises or low blood sugar events.
Recruiting
Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes
NA Los Angeles, California +4 sites NCT07521475
This trial is looking for adults with type 2 diabetes who are currently on insulin therapy. Participants will use the Omnipod® system to manage their diabetes over a 26-week period and may continue using it afterward.
Recruiting
CGM for Management of Type 2 Diabetes in Pregnancy
NA Portland, Oregon +4 sites NCT06628453
This trial is looking for pregnant women with type 2 diabetes to see if using a continuous glucose monitor is better than checking blood sugar with fingersticks. Participants will monitor their blood sugar, complete surveys, and provide blood samples during the trial.
Recruiting
Closed Loop Context Aware AID
NA Portland, Oregon NCT06676657
This trial is looking for adults with type 1 diabetes to test a new system for automatically delivering insulin. Participants will be monitored to see how well this new system controls blood sugar levels compared to a standard system.
Recruiting
CGM for the Early Detection and Management of Hyperglycemia in Pregnancy
NA Birmingham, Alabama +4 sites NCT06957028
This trial is looking for pregnant women to use a continuous glucose monitor to help detect and manage high blood sugar early in pregnancy. Participants will be monitored to ensure their health and the baby's health during the study.
Recruiting
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
PHASE3 Birmingham, Alabama +4 sites NCT07654374
This trial is looking for adults with obesity or overweight who also have type 2 diabetes. Participants will take either the drug aleniglipron or a placebo for 76 weeks to assess its effects.
Recruiting
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
PHASE3 Escondido, California +4 sites NCT07776509
This trial is looking for adults with obesity or overweight who have related health problems. Participants will take a medication called AZD6234 and will be compared to others taking a placebo over 68 weeks.
Recruiting
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
PHASE3 Birmingham, Alabama +4 sites NCT07743450
This trial is looking for adults with obesity or overweight who have type 2 diabetes. Participants will take a daily oral medication to see how well it works and how safe it is over time.
Recruiting
Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
PHASE3 Stanford, California +4 sites NCT06217302
This trial is looking for adults with type 1 diabetes and diabetic kidney disease. Participants will take either a study drug or a placebo for three years, while receiving education on managing their diabetes.
Recruiting
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
PHASE3 Anniston, Alabama +4 sites NCT07351045
This trial is looking for adults who are overweight or have obesity without type 2 diabetes. Participants will take a study drug or a placebo to help with weight management and will need to self-administer the treatment.
Recruiting
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
PHASE3 Birmingham, Alabama +4 sites NCT07667803
This trial is looking for adults with obesity or overweight. Participants will take a medication called elecoglipron while following a diet and exercise program to help manage their weight.
Recruiting
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
PHASE3 Birmingham, Alabama +4 sites NCT07282600
This trial is looking for people with obesity or overweight who also have type 2 diabetes. Participants will take eloralintide or a placebo for about 75 weeks to see if it helps with weight loss.
Recruiting
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
PHASE3 Dothan, Alabama +4 sites NCT07784725
This trial is looking for adults with obesity or overweight who have tried to lose weight before. Participants will take AZD6234 or a placebo for 68 weeks to see how it affects weight change.
Recruiting
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes
PHASE4 Phoenix, Arizona +4 sites NCT02915198
This trial is looking for veterans who are between 18 and 80 years old, have pre-diabetes, and have heart or blood vessel issues. They're not including anyone who has recently used certain diabetes medications or has severe kidney problems, liver disease, or other serious health conditions. It's important that participants haven't had recent severe blood sugar issues or any bad reactions to the medication being tested.
Recruiting
A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
PHASE2 Mobile, Alabama +4 sites NCT06368817
This trial is looking for children and young adults aged 3 to 30 who have been newly diagnosed with a specific type of brain tumor called germinoma. They need to have certain health markers confirming their condition, and most importantly, they should not have any other major health issues that might interfere with the study. If you're within this age range and have the right diagnosis, you could be a good fit for the trial.
Recruiting
Brown Adipose Tissue Activation by Spinal Cord Stimulation
NA Portland, Oregon NCT04326192
This trial is looking for adults with ongoing leg and back pain who are planning to have spinal cord stimulation (SCS) for pain relief. Participants will help evaluate if SCS can also aid in weight loss and improve metabolism.
Recruiting

Where the Diabetes studies are in Oregon

  • Oregon Health and Science University, Portland6 trials
  • Oregon Health & Science University, Portland3 trials
  • Research Site, Portland3 trials
  • ACCOMPLISH-2 Research Site, Portland1 trial
  • AURORA-2 Clinical Site, Eugene1 trial
  • Diabetes and Obesity Care, Bend1 trial

Counts are recruiting studies listing at least one site in Oregon, from ClinicalTrials.gov, refreshed every two days.

Diabetes clinical trials in Oregon: common questions

How many Diabetes clinical trials are recruiting in Oregon?
TrialFinder currently lists 21 recruiting Diabetes clinical trials with study sites in Oregon. Results are updated regularly from ClinicalTrials.gov, the official U.S. registry of clinical studies.
Where are Diabetes clinical trials located in Oregon?
Study sites for the Diabetes trials listed on this page include Bend, Portland. Each trial page lists every participating site with contact details, so you can find the location closest to you.
Do I need insurance to join a Diabetes clinical trial in Oregon?
No. Study-related care is covered by the trial sponsor at no cost to participants, including the study treatment, required lab tests and study visits. Many Diabetes trials in Oregon also compensate participants for time and travel. Health insurance is not required to search or enroll.
How do I qualify for a Diabetes clinical trial in Oregon?
Each study sets its own criteria based on age, Diabetes diagnosis details, prior treatments, current medications and general health. The fastest way to find out is to contact a research site directly — most will pre-screen you by phone in 10 to 15 minutes at no charge. You can also create a free TrialFinder profile to be matched automatically.
Can I join a diabetes clinical trial if I am already on medication?
Usually yes. Most type 2 diabetes trials enroll people on metformin or other oral medicines and test a new treatment on top of them; some require a stable dose for a few months first. Trials that exclude insulin or a specific drug say so in their criteria.
Do I need to know my A1c to apply?
No. Trials state an A1c range, but the study site measures it at the screening visit. You only need to know that you have been diagnosed and which type.
Are Clinical Trials Safe? What Patients Should Know
How clinical trial safety works — phases, IRB oversight, informed consent, and your right to withdraw — plus the real risks and questions to ask.
How to Know If You Qualify for a Clinical Trial
Every trial has eligibility criteria based on diagnosis, age, and medical history. Here's how to tell if you qualify — and what to do if you're not sure.
Clinical Trials Without Insurance: What You Need to Know
Clinical trials cover the cost of study-related care, making them one of the few ways to access treatment without health insurance. Here's what's covered.
All guides →

Check Your Eligibility

Create a free profile and our AI will match you to Diabetes trials near you in Oregon.

Get Matched — Free
No insurance required

Diabetes clinical trials study new treatments for Type 1, Type 2, and gestational diabetes, including insulin therapies, diet interventions, and islet-cell transplants.

All Diabetes trials →